Molecular Dynamics Insights into TAS1R2 Transmembrane Domain Activation
International Journal of Molecular Sciences · 26.11.2025 · 26 (23) · 11464
DOI: 10.3390/ijms262311464 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.11.2025. Verfasst von Yongcheng Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Sciences, Northeastern University, Bos…. Hauptthemen laut MEDLINE: Molecular Dynamics Simulation, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institute on Deafness and Other Communication Disorders at the National Institutes of Health.
Abstract (Originalsprache)
Sweet taste receptors (STRs) are class C G protein-coupled receptors (GPCRs) that function as heterodimers of TAS1R2 and TAS1R3. These receptors possess multiple binding sites and can be activated by a wide range of sweet-tasting compounds. Interestingly, TAS1R2 alone or even its extracellular domain-truncated form (TAS1R2-TMD), can act as a functional receptor. Previous studies demonstrated that the sweetener S819 and the sweet inhibitor amiloride act through the transmembrane domain (TMD) of TAS1R2; however, the molecular mechanisms underlying these ligand-specific effects remain unclear, largely due to the historical lack of experimentally determined full-length STR structures. Recent breakthroughs in cryo-EM structural determination of the full-length TAS1R2/TAS1R3 complex now offer an unprecedented opportunity to elucidate receptor activation mechanisms at atomic resolution. In this study, we investigated ligand-induced conformational dynamics of hTAS1R2-TMD using microsecond-scale molecular dynamics (MD) simulations on three systems: hTAS1R2-TMD/S819 (agonist-bound), hTAS1R2-TMD/amiloride (antagonist-bound), and hTAS1R2-TMD (apo). Comparative analyses revealed that agonist and antagonist binding distinctly modulate key structural switches, including the conserved ionic lock (E6.35-R3.50), which stabilizes the inactive state and disrupts upon activation. Notably, we identified a novel salt bridge (D7.32-R3.32) that forms preferentially in the active state, potentially serving as a unique molecular switch for TAS1R2. Additional analyses uncovered ligand-specific rearrangements in hydrogen-bonding and hydrophobic interaction networks. These results provide atomistic insights into how agonists and antagonists differentially modulate TAS1R2 activation and lay a structural foundation for designing novel sweeteners and taste modulators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Bouvé College of Health Sciences, Northeastern University, Boston, MA 02115, USA.
- Center for Drug Discovery, Northeastern University, Boston, MA 02115, USA.
ORCID-Profile: Yongcheng Lu, Meng Cui
Förderung
- NIH HHS
- National Institute on Deafness and Other Communication Disorders at the National Institutes of Health
Zitieren
APA
Lu, Y., Ma, X., Meng, Z., & Cui, M. (2025). Molecular Dynamics Insights into TAS1R2 Transmembrane Domain Activation. International Journal of Molecular Sciences, 26(23), 11464. https://doi.org/10.3390/ijms262311464
Vancouver
Lu Y, Ma X, Meng Z, Cui M. Molecular Dynamics Insights into TAS1R2 Transmembrane Domain Activation. International Journal of Molecular Sciences. 2025;26(23):11464. doi:10.3390/ijms262311464
BibTeX
@article{Lu2025,
author = {Lu, Yongcheng and Ma, Xinyi and Meng, Ziyue and Cui, Meng},
title = {Molecular Dynamics Insights into TAS1R2 Transmembrane Domain Activation},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {23},
pages = {11464},
doi = {10.3390/ijms262311464}
}
EUVIMED